CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment
Malignant hematologic diseases, also referred to as hematologic tumors, encompass a series of malignant proliferative disorders of the lymphopoietic system, including leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms. The dysregulation of inflammatory factors or chronic inflamma...
Saved in:
| Main Authors: | Yanquan Liu, Huanwen Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/5/716 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Breakthroughs in treatment for hematological malignancies: latest updates on molecular glue, PROTACs and RNA degraders from ASH 2024
by: Na Li, et al.
Published: (2025-03-01) -
Resveratrol and IL-6 Modulation of CXCL1 Expression and Viability in Human Breast Cancer Cell Lines Authors
by: Entkhab M. A. Alanisi, et al.
Published: (2025-07-01) -
Age-related and postmenopausal breast cancer progression and treatment management: The significance of pro-inflammatory cytokines and CXC chemokines
by: Amin Ullah, et al.
Published: (2025-09-01) -
HOXD1 regulates neural crest cells differentiation and polycerate development in sheep
by: Cheng Zhang, et al.
Published: (2025-04-01) -
VISTA in hematological malignancies: a review of the literature
by: Yuanjia Duan, et al.
Published: (2024-12-01)